Dolby Laboratories (DLB) Cash & Equivalents (2009 - 2026)

Dolby Laboratories (DLB) has 18 years of Cash & Equivalents data on file, last reported at $669.4 million in Q2 2026.

• Quarterly Cash & Equivalents fell 4.18% year-over-year to $669.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $669.4 million (down 4.18% YoY) and the FY2025 annual result came in at $701.9 million, up 45.61% from the prior year.
• Cash & Equivalents grew to $669.4 million in Q2 2026, from $594.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $900.4 million in Q2 2022 to a low of $482.0 million in Q3 2024.
• A 5-year average of $680.5 million and a median of $678.9 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 49.39% — and 2025, when it surged 45.61%.
• Tracing DLB's Cash & Equivalents over 5 years: stood at $626.2 million in 2022, then gained by 4.9% to $656.8 million in 2023, then fell by 20.71% to $520.8 million in 2024, then advanced by 23.62% to $643.8 million in 2025, then gained by 3.97% to $669.4 million in 2026.
• The last three Cash & Equivalents figures came in at $669.4 million (Q2 2026), $594.3 million (Q1 2026), and $643.8 million (Q4 2025), per Business Quant data.